Clenil® is a registered trademark of Chiesi Ltd. VolumaticTM is a trademark of GlaxoSmithKline UK Ltd.
PIP codes: Soprobec 50 mcg/actuation - 4098620, Soprobec 100 mcg/actuation- 4098638, Soprobec 200 mcg/actuation - 4098646, Soprobec 250 mcg/actuation - 4098653.
© 2021 Glenmark Pharmaceuticals Europe Ltd. All rights reserved. Date of preparation: February 2021 PP-UK-SOP-0035 V5
Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to medical_information@glenmarkpharma.com
or call 0800 458 0383.
By clicking this link, you are leaving the Tiogiva website and entering a third party website. Glenmark Pharmaceuticals has no control over the content and management of third party websites and cannot be held responsible or liable for this. Please check that the content of the website you are about to visit is suitable for you, and that you are the intended audience. It is recommended that you carefully read the legal notices and privacy and cookie policies of third party websites before accessing them.
If you wish to leave the site, please continue, or stay on this page.
By clicking this link, you are leaving the Tiogiva website and entering a third party website. Glenmark Pharmaceuticals has no control over the content and management of third party websites and cannot be held responsible or liable for this. Please check that the content of the website you are about to visit is suitable for you, and that you are the intended audience. It is recommended that you carefully read the legal notices and privacy and cookie policies of third party websites before accessing them.
If you wish to leave the site, please continue, or stay on this page.
By clicking this link, you are leaving the Tiogiva website and entering a third party website. Glenmark Pharmaceuticals has no control over the content and management of third party websites and cannot be held responsible or liable for this. Please check that the content of the website you are about to visit is suitable for you, and that you are the intended audience. It is recommended that you carefully read the legal notices and privacy and cookie policies of third party websites before accessing them.
If you wish to leave the site, please continue, or stay on this page.
By clicking this link, you are leaving the Tiogiva website and entering a third party website. Glenmark Pharmaceuticals has no control over the content and management of third party websites and cannot be held responsible or liable for this. Please check that the content of the website you are about to visit is suitable for you, and that you are the intended audience. It is recommended that you carefully read the legal notices and privacy and cookie policies of third party websites before accessing them.
If you wish to leave the site, please continue, or stay on this page.
By clicking this link, you are leaving the Tiogiva website and entering a third party website. Glenmark Pharmaceuticals has no control over the content and management of third party websites and cannot be held responsible or liable for this. Please check that the content of the website you are about to visit is suitable for you, and that you are the intended audience. It is recommended that you carefully read the legal notices and privacy and cookie policies of third party websites before accessing them.
If you wish to leave the site, please continue, or stay on this page.
By clicking this link, you are leaving the Tiogiva website and entering a third party website. Glenmark Pharmaceuticals has no control over the content and management of third party websites and cannot be held responsible or liable for this. Please check that the content of the website you are about to visit is suitable for you, and that you are the intended audience. It is recommended that you carefully read the legal notices and privacy and cookie policies of third party websites before accessing them.
If you wish to leave the site, please continue, or stay on this page.
By clicking this link, you are leaving the Tiogiva website and entering a third party website. Glenmark Pharmaceuticals has no control over the content and management of third party websites and cannot be held responsible or liable for this. Please check that the content of the website you are about to visit is suitable for you, and that you are the intended audience. It is recommended that you carefully read the legal notices and privacy and cookie policies of third party websites before accessing them.
If you wish to leave the site, please continue, or stay on this page.
By clicking this link, you are leaving the Tiogiva website and entering a third party website. Glenmark Pharmaceuticals has no control over the content and management of third party websites and cannot be held responsible or liable for this. Please check that the content of the website you are about to visit is suitable for you, and that you are the intended audience. It is recommended that you carefully read the legal notices and privacy and cookie policies of third party websites before accessing them.
If you wish to leave the site, please continue, or stay on this page.